Can Red Light Therapy Make Cancer Worse?

Red light therapy does not have a simple yes-or-no relationship with cancer. Whether it promotes tumor growth, inhibits it, or does nothing at all depends on the wavelength used, the energy dose delivered, and the type of cancer cell involved. Some lab experiments have shown red and near-infrared light stimulating cancer cell proliferation, while others using different settings on different cancers found no change or even reduced growth. The largest clinical dataset available, from cancer patients who received red light therapy during treatment for oral mucositis, actually found improved survival. This is a topic where the details matter far more than the headline.

What Red Light Does Inside Cells

Red and near-infrared light, roughly in the 600 to 1100 nanometer range, can be absorbed by a component of the energy-production chain inside mitochondria. When this happens, cells ramp up their production of ATP, the molecule cells use as fuel, and also generate a short burst of reactive oxygen species (ROS), which are chemically active molecules that serve as signaling agents at low levels but can damage cells at high levels.¹ This is a non-specific effect. The light does not distinguish between a healthy muscle cell and a cancer cell. Both have mitochondria, both can absorb the light, and both can respond by producing more energy. That biological indifference is exactly what makes the cancer question worth asking.

Why Dose Changes Everything

One of the most consistent findings across red light therapy research is a biphasic dose response, sometimes called the Arndt-Schulz curve. In plain terms, a small dose of light tends to stimulate cells, a moderate dose may begin to inhibit them, and a large dose can kill them.² This pattern shows up across cell types and across outcomes. Mitochondrial activity, ATP levels, and cell proliferation all tend to peak at a specific energy window, then decline as the dose climbs higher.³

A study on human fibroblasts (the connective-tissue cells used in wound healing) illustrated this clearly. At lower energy doses, cell numbers and mitochondrial activity both went up. At higher doses, both went down.⁴ That same pattern has been observed in brain injury research in mice, where the number of treatments and the energy per treatment both showed sweet spots beyond which the benefit reversed.³

For cancer, the biphasic curve creates a genuine dilemma. If the “stimulating” window exists for healthy cells, it plausibly exists for cancer cells too. The question is whether typical therapy doses land in that window for a given tumor type, and the answer turns out to be frustratingly inconsistent.

Lab Results That Raised Red Flags

Several cell-culture experiments have shown cancer cells growing faster after red or near-infrared light exposure. When melanoma cells were exposed to 808 nm near-infrared light, both their proliferation rate and their ability to migrate increased compared to other wavelengths. The researchers described a “significant tumor-stimulating effect” at that wavelength.⁵ Colon cancer cells exposed to 670 nm red light at a moderate energy level showed a measurable increase in proliferation after three days.⁶ And breast cancer cells of a particularly aggressive type showed increased proliferation when exposed to infrared laser light at higher energy levels.⁷

These findings are real and should not be dismissed. At the same time, they come with important caveats. Cell-culture experiments isolate cancer cells from the immune system, blood supply, and surrounding tissue that all influence tumor behavior in a living body. A cancer cell dividing faster in a dish does not guarantee a tumor growing faster in a person. And the specific light parameters that triggered stimulation varied from one cancer type to the next, which makes blanket warnings difficult to apply.

Lab Results That Found No Harm

For other cancer types tested under different conditions, researchers found no increase in aggressive behavior. Head and neck squamous cell carcinoma cell lines exposed to red light therapy showed no increase in cell migration, survival, or cancer stem cell formation. One cell line actually showed decreased proliferation under nutritional stress.⁸ Oral squamous cell carcinoma cells treated with daily red light therapy at moderate energy levels showed an inhibitory effect on cell viability and no promotion of cancer stem cell self-renewal or aggressive cellular markers.⁹

A recent experiment comparing normal mouse muscle cells to human lung cancer cells under the same light conditions found something interesting. The muscle cells showed the expected biphasic boost in viability and ATP production, peaking around 5 J/cm² under near-infrared light. The cancer cells, however, showed stable or slightly reduced viability, even as their reactive oxygen species levels rose. The researchers interpreted this as evidence that cancer cells have a distinct sensitivity to the oxidative stress generated by light therapy, one that does not translate into the same proliferative boost that healthy cells experience.¹⁰ This is a single study and should not be over-interpreted, but it challenges the assumption that what helps normal cells automatically helps tumor cells in the same way.

What Animal Models Show

The jump from cells in a dish to living animals is where the cancer-promotion concern gets tested more rigorously, and the results so far have been mostly reassuring, with some exceptions. In one study, mice bearing hundreds of implanted tumors received full-body 670 nm red light therapy twice daily at 5 J/cm² for 37 consecutive days. Measurements across 330 tumors showed no measurable effect on tumor growth compared to untreated controls.¹¹ That is a notable result given how long and how frequently the light was applied.

In a melanoma model, high-dose red light delivered by LED at the highest tested energy level significantly slowed tumor growth and increased the presence of immune cells associated with anti-tumor defense.¹² The light did not cause inflammation or skin damage in normal tissue, and the effect appeared to depend on reaching a threshold dose.

On the other side, a mouse model of chemically induced skin tumors showed that 642 nm red LED light increased tumor size, skin thickness, and inflammatory markers.¹³ This study specifically used a cancer-initiation model where the skin had already been chemically primed for tumor development, so it may say more about the risk of red light in the presence of pre-cancerous skin lesions than about its effect on established cancers elsewhere in the body. Still, it is the kind of result that makes blanket safety claims premature.

What Clinical Data Says About Cancer Patients

The most clinically relevant evidence comes from cancer patients who received red light therapy during their cancer treatment, primarily to prevent or treat oral mucositis, the painful mouth sores caused by chemotherapy and radiation. A large retrospective study followed cancer patients who received photobiomodulation therapy for oral mucositis and tracked their long-term survival. Patients who received the light therapy lived longer on average than those who did not, with survival increasing by more than half. For patients with advanced stage III and IV cancers receiving chemotherapy and radiation, more light therapy sessions were consistently associated with better outcomes.¹⁴

A systematic review examining whether photobiomodulation used for cancer treatment side effects caused tumor safety problems found that most studies reported no side effects and no evidence that the therapy led to tumor growth or recurrence.¹⁵ That said, researchers have also noted that the long-term safety data is still thin and that the field needs more rigorous follow-up studies before the question can be considered definitively settled.¹⁶

The improved survival in the mucositis studies likely reflects multiple factors. Patients with less severe mouth pain can keep eating, maintain nutrition, and tolerate their full course of chemotherapy or radiation instead of having doses reduced or skipped. The light therapy may not be directly fighting the cancer so much as keeping patients healthy enough to complete the treatment that is fighting the cancer.

The Immune System Angle

One of the more intriguing lines of research involves the effect of red and near-infrared light on immune cells within the tumor environment. A study using pulsed light therapy found that it could reduce exhaustion markers on CD8+ T cells, the immune cells responsible for killing tumor cells, and enhance their cancer-fighting function. This effect was localized: tumors on the opposite side of the body from the irradiated site showed no immune changes, suggesting the light was remodeling the local immune environment rather than triggering a body-wide response.¹⁷ The same study found that the treatment failed against pigmented melanoma, likely because melanin absorbed the light before it could reach the relevant cells.

A separate experiment using longer-wavelength near-infrared lasers also showed changes in T cell exhaustion markers within tumors, though these changes did not translate into improved immune killing function in that particular study.¹⁸ The picture emerging from immune research is cautiously optimistic: under certain conditions, light therapy may help the immune system recognize and attack tumors. But the conditions are narrow, and the research is early.

There is also a potential downside to how light affects the tumor neighborhood. Red and near-infrared light can promote the growth of new blood vessels by stimulating endothelial cells to produce growth signals and by increasing calcium signaling pathways that drive new vessel formation.¹⁹ New blood vessel formation is a good thing in wound healing, which is why red light therapy works well for that purpose. But tumors also need new blood vessels to grow, and anything that encourages vessel formation near a tumor could theoretically feed it. Whether the doses used in typical therapy create enough of this effect to matter clinically remains unknown.

Red Light as a Potential Chemotherapy Ally

Some of the most counterintuitive findings suggest red light therapy might actually make cancer treatment work better. In lab experiments with a drug-resistant breast cancer cell line, red light at 630 nm combined with the chemotherapy drug doxorubicin reduced the cells’ resistance to the drug. The light appeared to suppress the expression of several genes that cancer cells use to pump chemotherapy drugs back out before they can do their work.²⁰ Another study on head and neck tumor cells found that at higher energy levels, infrared light caused a buildup of DNA damage and elevated reactive oxygen species levels that pushed cells toward death, raising the possibility that carefully dosed light could soften up tumors for conventional therapies.²¹

These are early-stage findings, primarily from cell cultures, and the leap from lab bench to clinical practice is enormous. But they complicate the narrative that red light therapy is inherently dangerous for cancer patients. The same biological pathways that could feed a tumor at one dose might weaken it at another.

Why Wavelength and Cancer Type Both Matter

One of the reasons the evidence looks contradictory at first glance is that researchers are not always testing the same thing. The melanoma study that found tumor stimulation used 808 nm near-infrared light, while the melanoma study that found tumor inhibition used visible red LED light at much higher total energy.⁵¹² Melanoma is itself a complicated case because melanin, the pigment these tumors produce, absorbs light and converts it to heat, which changes the physics entirely. The pulsed light therapy that restored T cell function against unpigmented tumors failed against pigmented melanoma for exactly this reason.¹⁷

Cancer type matters as much as light type. The oral squamous cell carcinoma studies found inhibition where colon cancer studies found stimulation, even at overlapping wavelengths. This likely reflects fundamental differences in how these cancers handle oxidative stress, how fast their mitochondria cycle through energy production, and how they respond to the signaling molecules that light triggers. There is no single “cancer” response to red light, just as there is no single cancer.

At-Home Devices and Skin Concerns

The growing consumer market for red light therapy panels, masks, and handheld devices adds a layer of practical concern. Most of these products emit light in the 620 to 850 nm range at relatively low power, targeting skin rejuvenation, acne reduction, or general wellness. The mouse study that found 642 nm LEDs could promote skin tumor growth in animals with chemically induced pre-cancerous lesions is relevant here. The researchers explicitly called for better regulation of consumer LED devices, noting that people with undiagnosed skin conditions could be exposing developing lesions to light that accelerates their growth.¹³

This does not mean your red light panel will give you skin cancer. The animal model used a chemical initiation step that most people’s skin has not undergone. But if you have suspicious moles, a history of skin cancer, or any lesion you have not had checked, shining concentrated red light on it daily is not a benign act. The light cannot tell the difference between the cell you want to energize and the one you do not.

How Photobiomodulation Differs From Photodynamic Therapy

People sometimes confuse red light therapy, formally called photobiomodulation, with photodynamic therapy, a genuine cancer treatment used in oncology. The two are fundamentally different. Photodynamic therapy requires the patient to first take a photosensitizing drug that accumulates in tumor tissue. When light is then shone on the area, the drug generates extremely high levels of reactive oxygen species that destroy the tumor cells directly.²² Without the drug, the same light wavelengths used in photodynamic therapy would not kill cancer cells. Photobiomodulation, by contrast, uses no drug and works at much lower energy levels, stimulating cellular metabolism rather than destroying cells. The overlapping wavelengths are what cause the confusion, but the mechanisms and intentions are entirely different.

Some researchers are exploring whether the two approaches could be combined, using photobiomodulation to prime cells or modulate the immune environment and then following up with photodynamic therapy for the kill. This is experimental territory, but it reflects how far the field has moved from the simple question of whether light is “good” or “bad” for cancer.

What This Means If You Have Cancer or a History of It

If you are currently undergoing cancer treatment, the clinical evidence on oral mucositis suggests that photobiomodulation administered by trained practitioners using established protocols does not appear to promote tumor growth and may help you tolerate treatment better. Multiple oncology centers already incorporate it into supportive care for this reason. The systematic review finding no tumor safety issues across the available literature supports continued use in that context.¹⁵

If you are a cancer survivor considering at-home red light therapy for unrelated reasons like skin appearance or joint pain, the risk is almost certainly low, but “almost certainly” is doing some heavy lifting in that sentence. The cell-culture studies showing stimulation of specific cancer types are too varied to ignore entirely, even if animal and clinical data are more reassuring. A conversation with your oncologist, specifically mentioning the wavelength and dose of whatever device you are considering, is the minimum due diligence. And avoiding direct, prolonged exposure to any area where you have had cancer or where you have suspicious skin changes is common sense that the current science supports.